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A mutation in the Duffy antigen (DARC) that abrogates receptor expression and gives profound protection
against some malaria species has become almost universal in African populations. He et al. (2008) show
that this polymorphism also leads to significantly increased susceptibility to HIV-1 infection but, paradoxi-
cally, to prolonged survival in HIV-1-infected subjects.The Duffy antigen receptor for chemo-
kines (DARC) was first described as
a blood group antigen in 1950 after the
identification of antibodies against the
protein in the serum of a multiply-trans-
fused haemophiliac man named Duffy. It
became better known in the 1970s as the
cell-surface protein used by the malaria
parasite species Plasmodium vivax and
Plasmodium knowlesi to enter the red
blood cell. The Duffy negative phenotype
is due to homozygosity for a promoter
polymorphism (46C) that disrupts the
binding site for a transcription factor
(GATA-1) required for the DARC chemo-
kine receptor to be expressed on the cell
surface of erythrocytes. This genotype
has risen to very high frequencies (>90%)
inAfricanpopulations, explaining the rarity
of disease caused by Plasmodium vivax
in Africa.
However, it is increasingly appreciated
that the DARC receptor plays a complex
role in regulating chemokine levels, at
least in part due to its ability to bind che-
mokines and adsorb them onto the red
cell surface, thereby acting as a chemo-
kine reservoir or ‘‘sink.’’ Chemokines
binding to DARC can largely be catego-
rizedas ‘‘inflammatory’’ and includemem-
bers of both the CC and CXC chemokine
families. Chemokine binding to DARC
does not lead to intracellular signaling
but is thought toplay apart in homeostasis
either through clearance of inflammatory
chemokines from the circulation or main-
tenance of plasma levels by subsequent
release from the red cell surface (Pruen-
ster and Rot, 2006). The expression of
DARC extends to endothelial cells in
venules (where it may assist leucocyteemigration to sites of inflammation) and
cerebellar neurons (Hadley and Peiper,
1997), even in individuals lacking Duffy
antigen expression on red cells.
The identification of the chemokine re-
ceptor, CCR5, as the coreceptor neces-
sary for entry of primary strains of HIV-1
into CD4+ T cells focused the spotlight
on chemokines and their receptors in HIV
pathogenesis. A 32 base-pair deletion in
theCCR5 gene produces a truncated pro-
tein that is not expressed at the cell sur-
face and confers considerable protection
against infection in homozygotes and
against disease progression in heterozy-
gotes. In addition, CCR5 promoter haplo-
types associated with increased receptor
expression accelerate progression of
disease (Arenzana-Seisdedos and Par-
mentier, 2006). The trio of CC chemokines
that bind specifically to CCR5 (MIP1a,
MIP1b, and RANTES, encoded by
CCL3L1, CCL4/CCL4L1, and CCL5) were
shown tosuppressHIV-1 replication invitro
(Cocchi et al., 1995).High levels ofCCche-
mokines such as RANTES lead to slow
disease progression (Arenzana-Seisde-
dos and Parmentier, 2006), and people
with increased copy numbers of genes
for MIP-1aP/CCL3 have reduced suscep-
tibility to HIV infection and progress more
slowly to AIDS (Gonzalez et al., 2005).
RANTES/CCL5 promoter polymorphisms
that upregulate transcription delay the de-
velopment of AIDS (Arenzana-Seisdedos
and Parmentier, 2006). During disease
progression inHIV-1 infection, the tropism
of the virus frequently switches from
CCR5 to another coreceptor, CXCR4,
which is widely distributed on naive
T cells. A promoter polymorphism in theCell Host & Migene encoding the only known ligand for
CXCR4, SDF-1a, is associated with de-
layed disease progression in one study
(Arenzana-Seisdedos and Parmentier,
2006). Taken together, these data show
that chemokines and their receptors are
intimately linked with both susceptibility
to and subsequent disease progression
in HIV-1 infection.
Expression of the Duffy antigen does
not permit entry of HIV-1 (Doranz et al.,
1996), but in the current issue of Cell
Host &Microbe, He and colleagues show
that the virus binds to DARC, retaining
viability, and can subsequently be trans-
mitted to susceptible T cells. This mecha-
nism appears to be most efficient for
CCR5-using strains of HIV-1, which are
responsible for establishing primary HIV-1
infection in the majority of cases. Further
investigation of a potential role for DARC
in HIV-1 pathogenesis revealed a pro-
found impact of the Duffy negative
genotype on HIV-1 susceptibility. He and
colleagues studied 1266 HIV-1-infected
participants and 2218 control subjects
who were typed for the DARC46C poly-
morphism using standard techniques.
Homozygosity for the DARC 46C geno-
type was associated with a 40% increase
in HIV-1 infection; however, in people
already infected with HIV-1, the same ge-
notype led to slower disease progression.
In addition, the previously described
RANTES/CCL5 polymorphism was only
associated with more rapid disease pro-
gression in DARC-expressing individuals.
Why should the absence of the Duffy re-
ceptor lead to increased susceptibility to
HIV-1 infection? The potential of DARC
to bind HIV-1 virions in the circulationcrobe 4, July 17, 2008 ª2008 Elsevier Inc. 3
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DARC on the surface of the red blood cell binds to HIV-1, perhaps limiting the spread of the initial inoculum. Subsequently, however, the red cell could transport
the virus to T lymphocytes and possibly also to dendritic cells. Reduced DARC expression increases initial susceptibility to infection, although the exact
mechanism is not clear. Once infection has occurred, disease progression may potentially be slower in people lacking DARC because red blood cells loaded
with virus are not available to disseminate HIV to its targets throughout the body.and transmit them to permissible cells
would seem to be an advantage to the vi-
rus: although the adsorption of virus to red
cells could also result in trapping of newly
infecting virus in the DARC ‘‘sink,’’ the
greater affinity of DARC for X4 virus rather
than R5 strainsmakes this an unlikely pro-
tective mechanism. The answer presum-
ably lies in the ill-understood regulatory
role of DARC on chemokine homeostasis.
As DARC predominantly binds proinflam-
matory chemokines, the absence of
DARC may shift the chemokine balance
away from an inflammatory response to
relevant stimuli. For example, it has been
reported that DARC individuals have
lower circulating levels of MCP-1, which
do not rise to the same extent after expo-
sure to endotoxin (Mayr et al., 2008),4 Cell Host & Microbe 4, July 17, 2008 ª200thereby providing a potential mechanism
for reduced immune activation in re-
sponse to the translocation of bacterial
products that is believed to play a part
in HIV pathogenesis (Brenchley et al.,
2006). The findings of He and colleagues
should stimulate further studies to under-
stand better the role of this mysterious
receptor in regulating the chemokine en-
vironment and how this in turn affects
HIV-1 entry and subsequent replication
(Figure 1).
This study was conducted in African
Americans, a heterogeneous grouping
that derives from many distinct ethnic
groups originating from a number of dif-
ferent African countries. African Ameri-
cans also show considerable admixture
with genes of European origin and, for8 Elsevier Inc.these reasons, are generally considered
to be a poor choice for genetic studies
of relevance to African populations. How-
ever, in this case He and colleagues have
turned the European admixture to their
advantage, since the DARC 46 C allele
has almost reached fixation in pure Afri-
can populations. Thus, these studies
could not have been conducted in the
continent where the results are most rel-
evant. The presence of the European
derived T allele in the African American
participants enables an assessment to
be made of the effects at this locus by
providing sufficient numbers of heterozy-
gotes and homozygotes for adequate
statistical comparisons to be made. A
correction was made for population strat-
ification using a panel of 11 markers
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group, which predicted reported ethnicity
in this study with an accuracy of 98.1%. A
score representing the proportion of Eu-
ropean descent based on these markers
was calculated for each participant and
included in the logistic regression and
survival analysis models. This method
would not detect residual population
structure, which will undoubtedly exist in
these cohorts; however, it is a useful
approach for this particular study.
Interest in genetic association studies
has recently come to focus recently on
examining a large number of polymor-
phisms across the whole human genome.
One such study recently identified an RNA
polymerase, and other markers linked to
HIV-1 disease progression (Fellay et al.,
2007). It is interesting that apart from the
major histocompatibility complex (MHC),
this study did not identify previously
well-replicated associations with HIV-1
infection. While this may be simply be-
cause of the relatively low density of
markers used, it underlines the neces-
sity for well-constructed, mechanistically
driven investigations of the effects of
functionally important candidate genes
of the kind presented in this study. Candi-Stabbing in the BA
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Paradoxically, plant pathogens poss
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For a generation of teachers and students,
it has been a nightmare to teach the clas-
sic gene-for-gene theory, which explains
plant immunity against specific patho-
gens. According to this theory, plants
possess dominant resistance (R) genes,
whichmatch specific dominant avirulence
(Avr) genes of pathogens. It is easy todate gene studies have contributed con-
siderably thus far to understanding the
molecular pathogenesis of HIV-1 infection
and should be seen as complementary to
the genome-wide approach.
The rapid spread of HIV-1 throughout
much of sub-Saharan Africa cannot be
entirely explained by social and economic
factors. The CCR5D32 resistance poly-
morphism is not found in Africans, but its
relative rarity even in Caucasians of
Northern European ancestry makes it un-
likely that the absence of this protective
genotype is sufficient to explain the dev-
astating levels of HIV-1 infection in African
populations. He and colleagues estimate
that the population attributable fraction
(PAF) of the DARC 46C/C genotype is
close to 11% in the African setting.
Thus, the almost universal presence of
the HIV-susceptible DARC genotype in
Africansmay be an important contribution
to understanding the massive extent of
the HIV-1 epidemic in Africa.
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